Sophia Genetics SA
SOPH
View Detailed Chart
4.800USD
+0.200+4.35%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
325.67MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+4.35%
5 Days
-8.57%
1 Month
0.00%
6 Months
+52.47%
Year to Date
+2.78%
1 Year
+34.45%
View Detailed Chart
TradingKey Stock Score of Sophia Genetics SA
Currency: USD Updated: 2026-02-06Key Insights
Sophia Genetics SA's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 152 out of 482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 7.33.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sophia Genetics SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Sophia Genetics SA Highlights
StrengthsRisks
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 37.03% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.17M.
Undervalued
The company’s latest PE is -4.30, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 26.90M shares, decreasing 31.90% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 30.80K shares of this stock.
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
7.333
Target Price
+59.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Sophia Genetics SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Sophia Genetics SA Info
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Ticker SymbolSOPH
CompanySophia Genetics SA
CEOCamblong (Jurgi)
Websitehttps://www.sophiagenetics.com/
Related Instruments
-2.48%
-2.53%
+1.90%
-1.31%
+0.74%
-0.57%
+4.65%
+3.01%
+1.64%
+4.53%
+3.03%
+3.00%
+0.73%
-0.59%
+3.65%
+3.01%
+0.73%
+8.39%
-0.37%
+2.94%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69265.370
-704.760 (-1.01%)
282.580
+22.390 (+8.61%)
2045.000
-6.730 (-0.33%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
